Oncolytics Biotech Inc. (NASDAQ: ONCY)
$1.07
-0.0100 ( -0.93% ) 123.0K
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.
Market Data
Open
$1.07
Previous close
$1.08
Volume
123.0K
Market cap
$80.70M
Day range
$1.07 - $1.09
52 week range
$0.88 - $3.08
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 2 | Oct 23, 2023 |
6-k | Quarterly Reports | 2 | Oct 20, 2023 |
6-k | Quarterly Reports | 2 | Oct 16, 2023 |
6-k | Quarterly Reports | 2 | Sep 26, 2023 |
6-k | Quarterly Reports | 2 | Sep 19, 2023 |
6-k | Quarterly Reports | 2 | Sep 06, 2023 |
6-k | Quarterly Reports | 7 | Aug 14, 2023 |
6-k | Quarterly Reports | 2 | Aug 14, 2023 |
6-k | Quarterly Reports | 2 | Aug 04, 2023 |
6-k | Quarterly Reports | 2 | Aug 04, 2023 |